Home » Prices » NASDAQ:CBLI

Cleveland BioLabs, Inc. stock price

Today's NASDAQ:CBLI chart, history & news

Price:
3.50 USD
Change:
+0.39 (12.54%)
Key Stats
Price open 3.15
Previous close 3.11
Market cap 46.68M
Volume 175.92K
Day high 3.5
Day low 3.117
Year high 4.26
Year low 0.5701
Year to date change 481.65%
P/E Ratio -17.28
Company Profile
Fundamentals
Insider Information
News

About Cleveland BioLabs, Inc.

Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Company information

Company name
Cleveland BioLabs Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
12
CEO
Christopher Zosh
Address
73 High Street, Buffalo, NY, 14203
Country
United States
Contact information
1.716.849.6810
Website
http://www.cbiolabs.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.